바이오포토닉스 시장 : 용도별, 최종 용도별 - 세계 예측(2025-2030년)

The Biophotonics Market was valued at USD 57.91 billion in 2023, expected to reach USD 63.14 billion in 2024, and is projected to grow at a CAGR of 9.12%, to USD 106.71 billion by 2030.

Biophotonics is an interdisciplinary field that involves the application of light-based technologies to study biological materials. It encompasses the development and use of photonic devices and techniques to analyze, image, and manipulate living tissues at the molecular and cellular levels. The necessity of biophotonics arises from its capability to provide non-invasive, high-resolution, and precise diagnostic and therapeutic solutions, significantly advancing medical research, diagnostics, and treatment. The primary applications include imaging systems like optical coherence tomography, microscopy, and spectroscopy, which play crucial roles in early disease detection, personalized medicine, and minimally invasive treatments. Key end-use sectors are healthcare, pharmaceuticals, biotechnology, and environmental monitoring, with healthcare being the principal driver due to rising demands for advanced diagnostic procedures and treatments.

In terms of market growth, biophotonics is influenced by technological advancements, increasing government funding for research, and heightened awareness of early disease detection techniques. The rise in chronic diseases and the aging global population further fuel the demand for innovative diagnostic and therapeutic solutions. Potential opportunities lie in expanding applications for telemedicine and remote diagnostics, driven by recent global health crises emphasizing the need for contactless healthcare solutions. However, challenges such as high costs of equipment, complex regulatory requirements, and lack of skilled professionals pose significant roadblocks. Additionally, rapid technological evolution necessitates constant investment in R&D, which may strain resources for smaller players.

Innovation in biophotonics can be directed towards cost-effective, portable diagnostic tools, and integration with artificial intelligence for enhanced data analysis and predictive diagnostics. Businesses should also explore nanoscale imaging and minimally invasive optical biosensors as potential growth areas. Collaborations between academia and industry could expedite technological advancements. The biophotonics market presents a dynamic and rapidly growing landscape, characterized by intense R&D activities and evolving technological paradigms. Companies can maintain a competitive edge by investing in emerging technologies, fostering cross-disciplinary collaborations, and tailoring solutions to meet the specific needs of healthcare providers and patients.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biophotonics Market

The Biophotonics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increase in geriatric populations
  • Development of novel Photoacoustic Tomography (PAT) System
  • Adoption biophotonics in cell and tissue diagnostics
• Market Restraints
  • Reluctance toward the adoption of new treatment practices
• Market Opportunities
  • Use of biophotonics in non-medical sectors
  • Emergence of nanotechnology
• Market Challenges
  • Lack of awareness of biophotonics technology

Porter's Five Forces: A Strategic Tool for Navigating the Biophotonics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biophotonics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biophotonics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biophotonics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biophotonics Market

A detailed market share analysis in the Biophotonics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biophotonics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biophotonics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biophotonics Market

A strategic analysis of the Biophotonics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biophotonics Market, highlighting leading vendors and their innovative profiles. These include Becton, Dickinson and Company, Carl Zeiss AG, Hamamatsu Photonics K.K., Idex Corporation, ImpediMed Limited, Lumenis Be Ltd., LUMICKS Technologies B.V., Magritek, Olympus Corporation, Oxford Instruments Group, PerkinElmer Inc., Photopharmics, Inc., Thermo Fisher Scientific Inc., THINKCYTE Inc., and VivoSight by Michelson Diagnostics Ltd..

Market Segmentation & Coverage

This research report categorizes the Biophotonics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Application, market is studied across Biosensors, Inside Imaging, Light Therapy, Microscopy, See-Through Imaging, Spectro Molecular, and Surface Imaging.
• Based on End-Use, market is studied across Medical Diagnostics, Medical Therapeutics, Non-Medical Application, and Tests & Components.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increase in geriatric populations
    • 5.1.1.2. Development of novel Photoacoustic Tomography (PAT) System
    • 5.1.1.3. Adoption biophotonics in cell and tissue diagnostics
  • 5.1.2. Restraints
    • 5.1.2.1. Reluctance toward the adoption of new treatment practices
  • 5.1.3. Opportunities
    • 5.1.3.1. Use of biophotonics in non-medical sectors
    • 5.1.3.2. Emergence of nanotechnology
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of awareness of biophotonics technology
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Biophotonics Market, by Application

• 6.1. Introduction
• 6.2. Biosensors
• 6.3. Inside Imaging
• 6.4. Light Therapy
• 6.5. Microscopy
• 6.6. See-Through Imaging
• 6.7. Spectro Molecular
• 6.8. Surface Imaging

7. Biophotonics Market, by End-Use

• 7.1. Introduction
• 7.2. Medical Diagnostics
• 7.3. Medical Therapeutics
• 7.4. Non-Medical Application
• 7.5. Tests & Components

8. Americas Biophotonics Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Biophotonics Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Biophotonics Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Becton, Dickinson and Company
• 2. Carl Zeiss AG
• 3. Hamamatsu Photonics K.K.
• 4. Idex Corporation
• 5. ImpediMed Limited
• 6. Lumenis Be Ltd.
• 7. LUMICKS Technologies B.V.
• 8. Magritek
• 9. Olympus Corporation
• 10. Oxford Instruments Group
• 11. PerkinElmer Inc.
• 12. Photopharmics, Inc.
• 13. Thermo Fisher Scientific Inc.
• 14. THINKCYTE Inc.
• 15. VivoSight by Michelson Diagnostics Ltd.